<DOC>
	<DOCNO>NCT00002044</DOCNO>
	<brief_summary>The purpose pilot study evaluate efficacy Retrovir ( AZT ) treatment AIDS-related dementia various neuromuscular complication . HIV lymphotropic neurotropic virus affect central peripheral nervous system ( CNS , PNS ) . There evidence CNS PNS may harbor virus latent state , potential continuous reinfection body system . Therefore , effective therapeutic effort HIV infection provide effective antiviral activity within nervous system .</brief_summary>
	<brief_title>A Pilot Study To Evaluate Effect Retrovir ( Zidovudine : AZT ) Treatment Human Immunodeficiency Virus ( HIV ) Associated Dementia Neuromuscular Diseases</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Neuromuscular Diseases</mesh_term>
	<mesh_term>AIDS Dementia Complex</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Coexisting Condition : Patients follow exclude : Past present renal disease . Significant bone marrow suppression . Blood transfusion within past month . Liver dysfunction . Evidence underlying , severe infection . Evidence active lifethreatening opportunistic infection study entry . Severe malabsorption ( patient recent significant weight loss must serum carotene level &gt; 75 IU/ml ) . Evidence nervous system dysfunction cause factor HIV infection , particularly cerebral toxoplasmosis , lymphoma , cryptococcal meningitis , chronic alcohol abuse , lead poisoning , cytomegalovirus ( CMV ) infection ( patient retinal CMV infection evidence CMV dementia ) , syphilis , progressive multifocal leukoencephalopathy . Other known cause nerve muscle disease . Hypersensitivity zidovudine ( AZT ) . Lymphoma tumor require cytotoxic chemotherapy . Concurrent Treatment : Allowed : Electron beam therapy area le 100 cm2 . Patients follow exclude : Past present renal disease . Significant bone marrow suppression . Blood transfusion within past month . Liver dysfunction . Evidence underlying , severe infection . Evidence active lifethreatening opportunistic infection study entry . Severe malabsorption ( patient recent significant weight loss must serum carotene level &gt; 75 IU/ml ) . Evidence nervous system dysfunction cause factor HIV infection , particularly cerebral toxoplasmosis , lymphoma , cryptococcal meningitis , chronic alcohol abuse , lead poisoning , cytomegalovirus ( CMV ) infection ( patient retinal CMV infection evidence CMV dementia ) , syphilis , progressive multifocal leukoencephalopathy . Other known cause nerve muscle disease . Hypersensitivity zidovudine ( AZT ) . Lymphoma tumor require cytotoxic chemotherapy . Patients AIDS ( CDC surveillance definition ) AIDS relate complex ( ARC ) . All patient must either : Dementia define progressive cognitive impairment absence alter consciousness think causally related HIV infection . Patients study fall low 20 percent ( less ) normal sample formal neuropsychological testing . OR One follow neuromuscular disease think related HIV infection : Demyelinating polyneuropathy , axonal polyneuropathy , inflammatory myopathy , unexplained progressive muscle weakness . Capacity give inform consent person durable power attorney give inform consent . Life expectancy = &gt; 4 month . Exclusion Criteria Concurrent Medication : Excluded : Cytotoxic chemotherapy . Steroids . Interferon . Immunomodulating agent . Concurrent Treatment : Excluded : Radiation therapy ( except electron beam therapy area le 100 cm2 ) . Prior Medication : Excluded within 4 week study entry : Cytotoxic chemotherapy . Any retroviral drug include limited zidovudine ( AZT ) , ribavirin , HPA 23 , AL721 , phosphonoformate . Steroids . Interferon . Immunomodulating agent . An anticipated need agent within next 16 week . Prior Treatment : Excluded within 1 month study entry : Radiation therapy ( except electron beam therapy area le 100 cm2 ) . Blood transfusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 1995</verification_date>
	<keyword>Pilot Projects</keyword>
	<keyword>Neuromuscular Diseases</keyword>
	<keyword>Drug Evaluation</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS Dementia Complex</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
</DOC>